PRESS-RELEASE ·Filed Jun 12, 2026

SCLX

Scilex Holding Company
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago WireGlobeNewswire
Press release: activist
Actionable Insight • Neutral

Monitor Semnur (SMNR) trading for price discovery post-spin. No immediate read-through for Scilex stock. This is a mechanical corporate event.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
SCLX ▼ -36.82% at T+60d
NEUTRAL call ✗ call lost -36.82% · α vs SPY -40.09% · entry $8.50 → $5.37
Entry anchored
Jun 11, 03:59 PM ET
via exchange tick
T+1d
-6.47%
call -6.47% · α -8.23%
$7.95
settled 4mo ago
T+5d
-12.12%
call -12.12% · α -12.79%
$7.47
settled 3mo ago
T+20d
+11.53%
call +11.53% · α +9.75%
$9.48
settled 3mo ago
T+60d
-36.82%
call -36.82% · α -40.09%
$5.37
settled 24d ago

Price Chart

Loading chart...

Executive Summary

Scilex Holding Company confirmed the payment date of June 15, 2026 for its previously announced dividend of Semnur Pharmaceuticals common stock to stockholders as of June 1, 2026. Each share of Scilex common stock will receive one share of Semnur, with the ex-dividend date set for June 16, 2026. This is a routine corporate action update with no financial impact on Scilex itself.

Key Facts

  • Dividend of Semnur common stock to Scilex stockholders confirmed for June 15, 2026 payment date.
  • Ex-dividend date set for June 16, 2026; record date was June 1, 2026.
  • Each share of Scilex common stock entitles holder to one share of Semnur common stock.

Financial Impact

No monetary value specified; dividend is in-kind stock distribution.

Risk Factors

  • Potential for the Board to change the record date or revoke the dividend (forward-looking risk).
  • Uncertainty in Semnur's valuation post-distribution.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3310993
11 reports for SCLX
Performance horizon
75% Hit rate 3 of 4 directional calls best @ T+60▲ +36.82%Jun 12, 2026
Filters
Rows
Reports for SCLX — sortable, filterable
TypeNow
Jul 22, 2026
10w ago
8-K
MIXED ★ 5/10
$7.39 $5.80▼ −21.52%▼ −24.82%$4.06 (−45.06%)
Jul 6, 2026
12w ago
8-K
MIXED ★ 6/10
$8.07 $6.67▼ −17.41%▼ −16.84%$4.06 (−49.69%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$7.80 $7.03▲ +9.87%▲ +8.84%$4.06 (+47.95%)
Jun 12, 2026
16w ago
Press Release
NEUTRAL ★ 2/10
$8.50 $9.48▲ +11.53%▲ +9.75%$4.06 (−52.24%)
Jun 12, 2026
16w ago
EFFECT
BEARISH ★ 6/10
$8.50 $9.48▼ −11.53%▼ −9.75%$4.06 (+52.24%)
Jun 11, 2026
16w ago
Institutional Cluster
NEUTRAL ★ 2/10
$8.70 $9.20▲ +5.75%▲ +3.86%$4.06 (−53.33%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 4/10
$4.72 $7.81▲ +65.47%▲ +66.85%$4.06 (−13.98%)
May 5, 2026
21w ago
Press Release
BULLISH ★ 8/10
$6.68 $4.46▼ −33.18%▼ −37.39%$4.06 (−39.23%)
May 4, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$6.94 $4.61▼ −33.63%▼ −39.42%$4.06 (−41.52%)
Apr 17, 2026
24w ago
Insider Cluster
MIXED ★ 6/10
$4.30 $3.92▼ −8.84%▼ −12.93%$4.06 (−5.50%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (56h 19m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 12, 2026